Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

103.41
Delayed Data
As of Apr 29
 -4.62 / -4.28%
Today’s Change
92.98
Today|||52-Week Range
140.72
-13.65%
Year-to-Date

Today’s Trading

Previous close108.03
Today’s open106.06
Day’s range102.39 - 108.34
Volume6,942,688
Average volume (3 months)6,047,722
Market cap$84.4B
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+20.59%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+16.47%
P/E ratio53.2
Price/Sales11.10
Price/Book14.36

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.93-1.22%
AGNAllergan-2.29-1.05%
AZNAstraZeneca-0.31-1.06%
ABBVAbbVie-0.20-0.33%
Data as of 4:04pm ET, 04/29/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.41
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers

Search for Jobs